Treating Leber hereditary optic neuropathy with idebenone: a plain language summary

This Plain Language Summary of Publication article (PLSP) from Expert Review of Ophthalmology examined idebenone’s effects on vision and safety in patients with Leber hereditary optic neuropathy (LHON), a rare genetic disease that causes vision loss due to mitochondrial dysfunction from DNA mutations. Researchers treated LHON patients with idebenone and compared their vision changes (improvement and/or slowed vision loss) to an untreated control group to assess the medication’s effectiveness.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial’ and was published in Cell Reports Medicine. 

Visit ScienceDirect using the link to read the original article.

• Blindness
• Genetic mutation
• Idebenone
• lay summary
• Leber hereditary optic neuropathy
• LHON
• Maternal inheritance
• Mitochondrial disease
• Plain language summary publication
• Vision loss